Dynacare Competitors and Similar CompaniesClear all

Dynacare's competitors and similar companies include NeoGenomics, SYNLAB International, LifeLabs and BBI Solutions.

	Dynacare Dynacare-Gamma Laboratory Partnership is a company that provides laboratory testing.	NeoGenomics NeoGenomics Laboratories is a provider of oncology diagnostic testing and consultative services.	SYNLAB International SYNLAB International is a company that offers medical laboratory services for practicing doctors, clinics, and the pharmaceutical industry.	LifeLabs LifeLabs is a laboratory testing service provider.	BBI Solutions BBI Solutions is a company that develops and manufactures immuno-diagnostics reagents.
Founding Date	Founding Date 1987	Founding Date 2002	Founding Date 2015	Founding Date 1958	Founding Date 1986
Type	Type Subsidiary	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech medical diagnostics	Tags Healthcare biotech medical diagnostics oncology	Tags Healthcare biotech holding company medical diagnostics	Tags Healthcare drug monitoring medical diagnostics	Tags Healthcare biotech medical diagnostics
Locations	Locations Brampton, CA HQ Edmonton, CA Laval, CA London, CA Montréal, CA Ottawa, CA Winnipeg, CA	Locations Fort Myers, US HQ Suzhou, CN Rolle, CH Aliso Viejo, US Atlanta, US Carlsbad, US Fort Myers, US see more	Locations München, DE HQ Paris, FR Monza, IT London, GB	Locations Toronto, CA HQ Burnaby, CA Mississauga, CA Surrey, CA Victoria, CA	Locations Crumlin, GB HQ Freiburg Im Breisgau, DE Cape Town, ZA Edinburgh, GB Porton Down, GB Sittingbourne, GB see more
Employees	Employees 1,819	Employees 2,100	Employees 7,0851% increase	Employees 4,0931% increase	Employees 3491% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $727.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £55.5m (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods $413m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods £25.4m (FY, 2020)
Gross profit	Gross profit N/A	Gross profit $314.3m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit £30.1m (FY, 2020)
Net income	Net income N/A	Net income ($108m) (FY, 2025)	Net income N/A	Net income N/A	Net income (£9.9m) (FY, 2020)
Operating ⚠
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) 3 (FY, 2021)	Trademarks (US) N/A	Trademarks (US) 2 (Mar, 2022)	Trademarks (US) N/A